IFOSFAMIDE/MESNA KIT Drug Patent Profile
✉ Email this page to a colleague
When do Ifosfamide/mesna Kit patents expire, and when can generic versions of Ifosfamide/mesna Kit launch?
Ifosfamide/mesna Kit is a drug marketed by Teva Pharms Usa and is included in one NDA.
The generic ingredient in IFOSFAMIDE/MESNA KIT is ifosfamide; mesna. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ifosfamide; mesna profile page.
Summary for IFOSFAMIDE/MESNA KIT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 453 |
Formulation / Manufacturing: | see details |
DailyMed Link: | IFOSFAMIDE/MESNA KIT at DailyMed |
Recent Clinical Trials for IFOSFAMIDE/MESNA KIT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Polaris Group | Phase 1/Phase 2 |
Washington University School of Medicine | Phase 1/Phase 2 |
David Bond, MD | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for IFOSFAMIDE/MESNA KIT
US Patents and Regulatory Information for IFOSFAMIDE/MESNA KIT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms Usa | IFOSFAMIDE/MESNA KIT | ifosfamide; mesna | INJECTABLE;INTRAVENOUS | 075874-001 | Feb 26, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Pharms Usa | IFOSFAMIDE/MESNA KIT | ifosfamide; mesna | INJECTABLE;INTRAVENOUS | 075874-002 | Feb 26, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |